We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

57 hedge funds and large institutions have $364M invested in ProQR Therapeutics in 2018 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

383% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 6

68% more funds holding

Funds holding: 34 → 57 (+23)

9.81% more ownership

Funds ownership: 51.49% → 61.3% (+9.8%)

3% less capital invested

Capital invested by funds: $378M → $364M (-$13.2M)

23% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 13

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
57
Holders Change
+23
Holders Change %
+67.65%
% of All Funds
1.27%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
29
Increased
10
Reduced
13
Closed
6
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$62.5M
2
UBS Group
UBS Group
Switzerland
+$52.4M
3
BlackRock
BlackRock
New York
+$12.9M
4
HSBC Holdings
HSBC Holdings
United Kingdom
+$9.18M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$8.82M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$60.4M
2
RG
Redmile Group
California
-$28.1M
3
O
OrbiMed
New York
-$11M
4
Morgan Stanley
Morgan Stanley
New York
-$1.69M
5
OAM
Oxford Asset Management
United Kingdom
-$1.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
FSA
26
Franklin Street Advisors
North Carolina
$947K – – –
CS
27
Credit Suisse
Switzerland
$833K -$383K -20,882 -28%
Citadel Advisors
28
Citadel Advisors
Florida
$819K +$954K +51,972 New
Swiss National Bank
29
Swiss National Bank
Switzerland
$735K +$855K +46,600 New
OAM
30
Oxford Asset Management
United Kingdom
$710K -$1.14M -61,945 -58%
State Street
31
State Street
Massachusetts
$677K +$788K +42,923 New
Northern Trust
32
Northern Trust
Illinois
$666K +$775K +42,197 New
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$660K +$768K +41,840 New
JG
34
Jefferies Group
New York
$631K +$734K +40,000 New
Allianz Asset Management
35
Allianz Asset Management
Germany
$613K +$716K +39,010 New
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$338K -$904K -49,250 -70%
Geode Capital Management
37
Geode Capital Management
Massachusetts
$302K +$43.6K +2,375 +14%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$292K +$340K +18,501 New
VEA
39
Virtus ETF Advisers
New York
$263K +$306K +16,682 New
TCIM
40
TIAA CREF Investment Management
New York
$259K +$301K +16,422 New
Vanguard Group
41
Vanguard Group
Pennsylvania
$237K +$276K +15,020 New
JGGDR
42
JGP Global Gestao de Recursos
Brazil
$235K -$13.7K -748 -5%
DTL
43
Dynamic Technology Lab
Singapore
$223K +$259K +14,103 New
Wells Fargo
44
Wells Fargo
California
$174K -$15.2K -830 -7%
EC
45
EcoR1 Capital
California
$174K +$202K +11,022 New
ProShare Advisors
46
ProShare Advisors
Maryland
$171K +$199K +10,820 New
Squarepoint
47
Squarepoint
New York
$169K +$196K +10,700 New
Deutsche Bank
48
Deutsche Bank
Germany
$137K +$161K +8,773 New
Mitsubishi UFJ Asset Management
49
Mitsubishi UFJ Asset Management
Japan
$124K +$128K +6,971 New
Zurich Cantonal Bank
50
Zurich Cantonal Bank
Switzerland
$53K +$61.6K +3,354 New
1
2
3

PRQR Hedge Fund Activity: Q4 2018 in Review

57 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q4 2018, worth a combined $364M — down 3.5% from $378M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new PRQR positions and 6 closed out — a net gain of 23 holders — while 10 added to existing stakes and 13 trimmed.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $62.5M. The largest seller was RTW Investments, cutting an estimated $60.4M.

  • 57 institutional investors held ProQR Therapeutics (PRQR) as of Q4 2018, up from 34 in Q3 2018.
  • Funds reported $364M of ProQR Therapeutics stock for Q4 2018, down 3.5% quarter-over-quarter.
  • 29 funds opened new ProQR Therapeutics positions in Q4 2018 and 6 closed out, a net change of +23 holders.
  • The largest ProQR Therapeutics buyer in Q4 2018 was Goldman Sachs, an estimated $62.5M added.
  • The largest ProQR Therapeutics seller in Q4 2018 was RTW Investments, an estimated $60.4M sold.

Based on aggregated 13F filings for Q4 2018.